Remission of psoriasis with nintedanib for the treatment of idiopathic pulmonary fibrosis

J Dermatol. 2019 Apr;46(4):e118-e119. doi: 10.1111/1346-8138.14641. Epub 2018 Sep 11.

Authors

Akari Murata¹, Satoshi Watanabe¹, Yuka Ikawa², Keigo Saeki¹, Kenta Yamamura¹, Hiroki Matsuoka¹, Kota Tanimura¹, Yuichi Tambo¹, Kazuo Kasahara¹

Affiliations

¹ Department of Respiratory Medicine, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.
² Department of Dermatology, Kanazawa University Graduate School of Medical Sciences, Kanazawa, Japan.

PMID: 30204265
DOI: 10.1111/1346-8138.14641

No abstract available

Publication types

Case Reports
Letter

MeSH terms

Aged
Humans
Idiopathic Pulmonary Fibrosis / complications
Idiopathic Pulmonary Fibrosis / drug therapy*
Indoles / therapeutic use*
Male
Protein Kinase Inhibitors / therapeutic use*
Psoriasis / complications
Psoriasis / diagnosis
Psoriasis / drug therapy*
Remission Induction / methods
Severity of Illness Index
Treatment Outcome

Substances

Indoles
Protein Kinase Inhibitors
nintedanib